by Peter Ciszewski | Nov 9, 2020
Molly Mager and Carri Levy, co-creators of Behind the Mystery, talk about their favorite episodes. Behind the Mystery is a recurring segment on Lifetime Channel’s The Balancing Act that is devoted to rare and genetic conditions. The two producers have created...
by Peter Ciszewski | Nov 6, 2020
Andrew Krivoshik, MD, PhD, Oncology Therapeutic Area Head at Astellas Pharma talks about Be R/Ready, a resource for patients with relapsed or refractory acute myeloid leukemia (AML) and their physicians. AML is a rare aggressive cancer of the blood and bone...
by Peter Ciszewski | Nov 4, 2020
Justin Hopkin, MD, Board Chair for the National Niemann-Pick Disease Foundation (NNPDF) talks about the changes their foundation has made to keep their families connected and informed during the Covid-19 pandemic. Dr. Hopkin is the father of a child with Acid...
by Peter Ciszewski | Nov 3, 2020
Carri Levy, Producer of Behind the Mystery, talks about the origins of the show as it celebrates its 100th segment. Behind the Mystery is a recurring segment on Lifetime Channel’s The Balancing Act that is devoted to rare and genetic diseases. Each episode...
by Peter Ciszewski | Nov 2, 2020
Eric Jonasch, MD, Professor, Department of Genitourinary Medical Oncology at MD Anderson Cancer Center, discusses data presented on MK-6482 for the treatment of renal cell carcinoma associated with von Hippel-Lindau disease. Von Hippel-Lindau disease is a...
